Jafron Biomedical Co.,Ltd.

Informe acción SZSE:300529

Capitalización de mercado: CN¥23.7b

Jafron BiomedicalLtd Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Fan Dong

Chief Executive Officer (CEO)

CN¥3.7m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO14.2yrs
Participación del CEO45.9%
Permanencia media de la dirección1.9yrs
Promedio de permanencia en la Junta Directiva3.4yrs

Actualizaciones recientes de la dirección

Recent updates

Earnings Report: Jafron Biomedical Co.,Ltd. Missed Revenue Estimates By 8.1%

Oct 21
Earnings Report: Jafron Biomedical Co.,Ltd. Missed Revenue Estimates By 8.1%

Further Upside For Jafron Biomedical Co.,Ltd. (SZSE:300529) Shares Could Introduce Price Risks After 34% Bounce

Oct 02
Further Upside For Jafron Biomedical Co.,Ltd. (SZSE:300529) Shares Could Introduce Price Risks After 34% Bounce

Estimating The Fair Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

Sep 09
Estimating The Fair Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

The Returns On Capital At Jafron BiomedicalLtd (SZSE:300529) Don't Inspire Confidence

Aug 25
The Returns On Capital At Jafron BiomedicalLtd (SZSE:300529) Don't Inspire Confidence

Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

May 28
Jafron BiomedicalLtd's (SZSE:300529) Dividend Will Be Reduced To CN¥0.40

A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

May 24
A Look At The Intrinsic Value Of Jafron Biomedical Co.,Ltd. (SZSE:300529)

Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

May 08
Why Investors Shouldn't Be Surprised By Jafron Biomedical Co.,Ltd.'s (SZSE:300529) 30% Share Price Surge

Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

May 02
Jafron BiomedicalLtd's (SZSE:300529) Soft Earnings Don't Show The Whole Picture

Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Apr 13
Investors Could Be Concerned With Jafron BiomedicalLtd's (SZSE:300529) Returns On Capital

Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Mar 22
Does Jafron BiomedicalLtd (SZSE:300529) Have A Healthy Balance Sheet?

Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

Mar 04
Jafron Biomedical Co.,Ltd.'s (SZSE:300529) P/E Is Still On The Mark Following 31% Share Price Bounce

CEO

Fan Dong (54 yo)

14.2yrs

Permanencia

CN¥3,741,000

Compensación

Mr. Fan Dong serves as Chairman of Board of Directors and General Manager at Jafron Biomedical Co., Ltd. He serves as Director since April 27, 2023 at Jafron Biomedical Co.,Ltd. He served as Company Secret...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Fan Dong
Chairman of Board of Directors & GMno dataCN¥3.74m45.86%
CN¥ 10.9b
Xueyun Liao
Director & Financial Director1.6yrsCN¥500.50k0.019%
CN¥ 4.5m
De Zhi Li
Deputy General Managerno dataCN¥865.40k0.46%
CN¥ 108.4m
Xian Min Tang
Deputy GM & Directorno dataCN¥2.65m2.76%
CN¥ 653.1m
Aijun Wu
Deputy General Manager4.5yrsCN¥2.44m0.031%
CN¥ 7.4m
Rui Wang
General Manager1.2yrsCN¥510.40ksin datos
Cong Huang
Board Secretary2.2yrsCN¥455.20k0.00044%
CN¥ 104.3k

1.9yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300529 no se considera experimentado ( 1.9 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Fan Dong
Chairman of Board of Directors & GM14.2yrsCN¥3.74m45.86%
CN¥ 10.9b
Xueyun Liao
Director & Financial Directorless than a yearCN¥500.50k0.019%
CN¥ 4.5m
Xian Min Tang
Deputy GM & Director14.2yrsCN¥2.65m2.76%
CN¥ 653.1m
Claudio Ronco
Member of Global Advisory Board3.4yrssin datossin datos
Feng Li
Non-Independent Director4.6yrsCN¥1.08m0.099%
CN¥ 23.4m
Xiaohong Peng
Chairman of Supervisory Board4.6yrssin datossin datos
Wen Lei
Non-Independent Director4.6yrsCN¥177.20ksin datos
Rinaldo Bellomo
Member of Global Advisory Board3.4yrssin datossin datos
Thomas Rimmelé
Member of Global Advisory Board3.4yrssin datossin datos
John Prowle
Member of Global Advisory Board3.4yrssin datossin datos
Antoine Schneider
Member of Global Advisory Board3.4yrssin datossin datos
Olivier Joannes-Boyau
Member of Global Advisory Board3.4yrssin datossin datos

3.4yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de 300529 se considera experimentada (3.4 años de antigüedad promedio).